WallStreetZenWallStreetZen

NYSE: IQV
Iqvia Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IQV

Based on 9 analysts offering 12 month price targets for Iqvia Holdings Inc

Min Forecast
$177.00-13.47%
Avg Forecast
$217.56+6.36%
Max Forecast
$240.00+17.33%

Should I buy or sell IQV stock?

Based on 9 analysts offering ratings for Iqvia Holdings Inc.

Strong Buy
Strong Buy
5 analysts 55.56%
Buy
2 analysts 22.22%
Hold
2 analysts 22.22%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IQV's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IQV as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their IQV stock forecasts and price targets.

IQV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-09
lockedlocked$00.00+00.00%2025-10-08
lockedlocked$00.00+00.00%2025-10-02
lockedlocked$00.00+00.00%2025-09-09Find Out Why
lockedlocked$00.00+00.00%2025-07-25
UBS
Top 12%
89
Strong BuyMaintains$225.00+10.00%2025-07-23
Truist Securities
Bottom 1%
1
Strong BuyMaintains$235.00+14.89%2025-07-23
Baird
Top 23%
78
HoldMaintains$196.00-4.18%2025-07-23
JP Morgan
Bottom 6%
6
Strong BuyMaintains$177.00-13.47%2025-05-19

1 of 1

Forecast return on equity

Is IQV forecast to generate an efficient return?

Company
43.41%
Industry
71.38%
Market
-62.31%
IQV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IQV forecast to generate an efficient return on assets?

Company
8.76%
Industry
20.98%
IQV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IQV earnings per share forecast

What is IQV's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$10.73+53.95%
Avg 2 year Forecast
$11.81+69.46%
Avg 3 year Forecast
$13.30+90.79%
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

IQV revenue forecast

What is IQV's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$16.2B+2.95%
Avg 2 year Forecast
$17.0B+8.22%
Avg 3 year Forecast
$17.9B+14.22%
IQV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IQV earnings growth forecast

How is IQV forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
23.76%
Industry
15.55%
Market
16%
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
IQV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

IQV revenue growth forecast

How is IQV forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
4.48%
Industry
5.38%
Market
11.86%
IQV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IQV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IQV vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
IQV$204.55$217.56+6.36%Strong Buy
A$141.92$152.90+7.74%Strong Buy
MTD$1,349.28$1,322.78-1.96%Buy
NTRA$181.69$203.88+12.21%Strong Buy
LH$285.94$304.75+6.58%Buy
View Top Diagnostic & Research Stocks

Iqvia Holdings Stock Forecast FAQ

Is Iqvia Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: IQV) stock is to Strong Buy IQV stock.

Out of 9 analysts, 5 (55.56%) are recommending IQV as a Strong Buy, 2 (22.22%) are recommending IQV as a Buy, 2 (22.22%) are recommending IQV as a Hold, 0 (0%) are recommending IQV as a Sell, and 0 (0%) are recommending IQV as a Strong Sell.

If you're new to stock investing, here's how to buy Iqvia Holdings stock.

What is IQV's earnings growth forecast for 2025-2027?

(NYSE: IQV) Iqvia Holdings's forecast annual earnings growth rate of 23.76% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 15.55%, and it is also forecast to beat the US market's average forecast earnings growth rate of 16%.

Iqvia Holdings's earnings in 2025 is $1,237,000,000.On average, 8 Wall Street analysts forecast IQV's earnings for 2025 to be $1,824,100,000, with the lowest IQV earnings forecast at $1,800,300,000, and the highest IQV earnings forecast at $1,859,800,000. On average, 8 Wall Street analysts forecast IQV's earnings for 2026 to be $2,007,921,000, with the lowest IQV earnings forecast at $1,963,500,000, and the highest IQV earnings forecast at $2,048,500,000.

In 2027, IQV is forecast to generate $2,260,711,000 in earnings, with the lowest earnings forecast at $2,210,000,000 and the highest earnings forecast at $2,344,300,000.

What is IQV's revenue growth forecast for 2025-2027?

(NYSE: IQV) Iqvia Holdings's forecast annual revenue growth rate of 4.48% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.86%.

Iqvia Holdings's revenue in 2025 is $15,700,000,000.On average, 7 Wall Street analysts forecast IQV's revenue for 2025 to be $2,747,664,610,000, with the lowest IQV revenue forecast at $2,738,240,150,000, and the highest IQV revenue forecast at $2,755,101,600,000. On average, 8 Wall Street analysts forecast IQV's revenue for 2026 to be $2,888,495,840,000, with the lowest IQV revenue forecast at $2,854,968,100,000, and the highest IQV revenue forecast at $2,930,630,000,000.

In 2027, IQV is forecast to generate $3,048,437,280,000 in revenue, with the lowest revenue forecast at $3,011,903,600,000 and the highest revenue forecast at $3,130,878,100,000.

What is IQV's forecast return on assets (ROA) for 2025-2028?

(NYSE: IQV) forecast ROA is 8.76%, which is lower than the forecast US Diagnostics & Research industry average of 20.98%.

What is IQV's Price Target?

According to 9 Wall Street analysts that have issued a 1 year IQV price target, the average IQV price target is $217.56, with the highest IQV stock price forecast at $240.00 and the lowest IQV stock price forecast at $177.00.

On average, Wall Street analysts predict that Iqvia Holdings's share price could reach $217.56 by Oct 9, 2026. The average Iqvia Holdings stock price prediction forecasts a potential upside of 6.36% from the current IQV share price of $204.55.

What is IQV's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: IQV) Iqvia Holdings's current Earnings Per Share (EPS) is $6.97. On average, analysts forecast that IQV's EPS will be $10.73 for 2025, with the lowest EPS forecast at $10.59, and the highest EPS forecast at $10.94. On average, analysts forecast that IQV's EPS will be $11.81 for 2026, with the lowest EPS forecast at $11.55, and the highest EPS forecast at $12.05. In 2027, IQV's EPS is forecast to hit $13.30 (min: $13.00, max: $13.79).

What is IQV's forecast return on equity (ROE) for 2025-2028?

(NYSE: IQV) forecast ROE is 43.41%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.